Oxygen & Hyperbaric - The basics
Why dissolved oxygen is the whole point
Last updated 3 October 2026. How we write this .
Dissolved oxygen explains how HBOT can raise blood oxygen beyond haemoglobin's usual capacity. The mechanism is established, but benefits depend on the condition and evidence.
Start here Dissolved oxygen explains how HBOT can raise blood oxygen beyond haemoglobin's usual capacity. The mechanism is established, but benefits depend on the condition and evidence.
By the end, you will understand Two ways blood carries oxygen Why pressure changes the dissolved fraction Getting oxygen from blood into tissue Key words used in this lesson Prescription-only medicine A licensed medicine that may lawfully be supplied only against a prescription following clinical assessment. The lawful route to one is a qualified prescriber and a registered pharmacy. Hyperbaric Above normal atmospheric pressure. Hyperbaric oxygen therapy involves breathing oxygen in a pressurised chamber, which increases the amount dissolved in the blood. Full plain-English glossary
Where this information comes from Claim-cited evidence. Central research claims on this lesson are linked to specific studies or official guidance.
This lesson links the specific studies and guidance used for its central claims.
Our standard: expert or athlete opinion may illustrate a viewpoint, but it is never treated as proof. Read the editorial policy .
Report an error or outdated claim .
Dissolved oxygen is central to hyperbaric oxygen therapy, or HBOT, because it allows blood to carry additional oxygen when haemoglobin is already almost fully loaded. Raised oxygen pressure increases the amount dissolved directly in blood's watery component, including plasma, and strengthens the gradient moving oxygen towards tissues. This mechanism is well established, but it does not establish that extra oxygen improves health in every setting.
Two ways blood carries oxygen
Under ordinary conditions, almost all the oxygen in blood is attached to haemoglobin, the oxygen-binding protein inside red blood cells. A much smaller amount is physically dissolved in plasma and the water inside those cells. Dissolved oxygen consists of individual molecules in solution, not bubbles circulating through blood vessels.
In a healthy person breathing ordinary air at sea level, haemoglobin in blood leaving the lungs is usually close to fully saturated. That qualification matters: blood returning from tissues has unloaded some oxygen, and lung disease or altitude can change the starting position. Near-full saturation describes normal arterial blood, not every blood vessel or every person.
Haemoglobin is both a carrier and a reservoir. As dissolved oxygen moves from blood into tissues, haemoglobin releases more into the dissolved pool. Oxygen attached to haemoglobin must detach before it can diffuse into cells. The small dissolved fraction therefore plays an essential role even when it contributes little to the total oxygen carried.
Why pressure changes the dissolved fraction
Henry's law describes the relationship: at a given temperature, the amount of a gas dissolved in a liquid increases with that gas's partial pressure. Partial pressure means the contribution one gas makes to the pressure of a mixture. For oxygen transport, oxygen's partial pressure matters more than a chamber pressure figure considered alone.
HBOT combines raised surrounding pressure with oxygen-rich breathing gas. This increases oxygen pressure in the lungs and, where gas exchange is functioning, in arterial blood. Once haemoglobin is nearly full, much of the additional oxygen content comes from the growing dissolved fraction. Pressure does not create extra binding sites on haemoglobin.
Oxygen-rich gas at ordinary atmospheric pressure can also increase dissolved oxygen. Hyperbaric conditions can increase it further. This explains why pressure and oxygen concentration both matter when interpreting research, without assuming that any two experiences described as 'hyperbaric' produce equivalent biological effects.
Getting oxygen from blood into tissue
Oxygen moves by diffusion from regions of higher oxygen partial pressure towards regions of lower pressure. Cells continually consume oxygen, helping maintain this gradient. Raising oxygen pressure in nearby capillaries can strengthen the gradient and, under suitable conditions, allow oxygen to reach further into surrounding tissue.
The phrase 'reaches places red blood cells cannot' needs care. Red blood cells normally remain inside vessels; they do not enter surrounding tissue to deliver their cargo. Oxygen crosses the vessel wall as dissolved molecules. Additional dissolved oxygen may help when delivery through the smallest vessels is compromised, but it cannot guarantee access to tissue with no effective blood supply.
Delivery also depends on blood flow, diffusion distance and oxygen consumption. Swelling can increase the distance between vessels and cells. Poor circulation can reduce how much oxygen-bearing blood arrives. A high oxygen content in a blood sample therefore does not prove that every tissue receives enough, or that damaged cells can use what arrives.
What cells might do with extra oxygen
Mitochondria use oxygen in the chain of reactions that produces much of a cell's usable energy. Oxygen also supports reactions involved in collagen formation and some immune-cell functions. Where oxygen availability limits these processes, increasing its supply provides a plausible reason for a biological effect.
However, oxygen is only one requirement. Cells also need nutrients, functioning enzymes and adequate circulation. When oxygen supply already meets demand, adding more does not automatically increase energy production, physical performance or repair. An engine does not necessarily work better simply because one input becomes more abundant.
Higher oxygen exposure can also change chemical signalling and increase reactive oxygen molecules. These molecules participate in normal signalling, but excessive amounts can damage cellular components. Mechanistic and animal studies help investigate these competing effects; they cannot establish the balance of benefit and harm for an individual person.
A reliable physical effect is not the same as a reliable health benefit. Increased dissolved oxygen, increased tissue oxygen and improved everyday function are separate findings that require different measurements.
What human evidence actually shows
The physical rise in dissolved oxygen is supported by established physiology and direct measurement. Clinical outcomes require a different evidence base: studies comparing otherwise similar people, measuring outcomes that matter, and tracking unwanted effects. The strength of that evidence varies by condition, so a single verdict on HBOT for every purpose would be misleading.
For example, the 2023 Cochrane review of late radiation tissue injury assessed randomised trials and found possible benefits in selected affected tissues. Certainty for important benefits was generally low to moderate, with limitations including small studies and weaknesses in reporting. Those findings concern particular complications after radiotherapy; they do not establish general benefits for healthy people.
Longevity claims require particular caution. A small prospective study published in 2020 reported changes in telomere length in certain blood cells after HBOT. Telomeres are protective structures at chromosome ends. The study lacked a control group, and a change in this laboratory marker does not demonstrate longer life, less disability or reversal of whole-body ageing.
Observational reports can identify patterns but struggle to separate HBOT from concurrent care and differences between participants. Randomised trials improve that comparison, although small samples, incomplete follow-up and difficulty creating a convincing comparison experience can still limit confidence. Neither a compelling testimonial nor a statistically significant laboratory result resolves those problems.
Who the explanation applies to
The physics applies broadly, but its clinical relevance depends on the starting problem. A person with oxygen-limited tissue is not equivalent to a healthy person whose oxygen supply already meets demand. Findings in a narrowly selected patient group cannot simply be transferred to athletes, healthy older adults or people with unexplained tiredness.
Nor does the explanation mean haemoglobin becomes unnecessary. Red blood cells remain fundamental to normal oxygen transport, and increased dissolved oxygen is linked to the exposure conditions. It is not a permanent oxygen store. Any claim of lasting benefit needs evidence of lasting biological or functional change after the temporary oxygen increase has passed.
How to judge a dissolved-oxygen claim
A claim can describe the mechanism accurately and still overstate its significance. The useful question is whether the evidence connects the proposed mechanism to a meaningful outcome in the population being discussed.
What increased: dissolved oxygen, total blood oxygen, local tissue oxygen or an outcome such as function? These measurements answer different questions. What does a quoted increase use as its baseline? A large relative increase in a small fraction is not the same increase in total oxygen content. Who took part, and what comparison group was used? Healthy volunteers and patients with a specific tissue injury are not interchangeable. Did benefits persist, and were adverse effects reported? An immediate measurement cannot establish a lasting benefit. Does the conclusion match the study? Cell markers and animal findings can support a hypothesis without proving a benefit in people. A consumer pulse oximeter estimates haemoglobin saturation; it does not directly measure dissolved oxygen or total oxygen delivery. An almost unchanged reading therefore cannot confirm or dismiss the dissolved-oxygen mechanism. Equally, a reassuring reading does not establish that a chamber exposure is appropriate or safe.
Safety remains a separate judgement
Pressure changes can injure ears and sinuses, and oxygen exposure can cause temporary visual changes or oxygen toxicity. Medical oxygen is a prescription-only medicine in the UK; questions belong with a GP, pharmacist or relevant care team. People with an existing condition should involve their care team and must not change prescribed medicines based on a consumer device.
New ear pain, chest discomfort or breathing difficulty during an exposure should prompt an immediate request to stop and alert chamber staff. Call 999 for severe difficulty breathing or a tight or heavy chest. Sudden hearing loss needs an urgent GP appointment or NHS 111; persistent ear pain also warrants medical assessment.
This lesson is general education, not medical advice or a recommendation to use or avoid hyperbaric treatment. Decisions about hyperbaric oxygen belong with a qualified clinician.
Related in this classroom The studies behind this page Hypoxia and hyperbaric oxygen therapy: a review - International Journal of General Medicine, 2018Hyperbaric oxygen treatment: effects on mitochondrial function and oxidative stress - Biomolecules, 2021Sources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.